Stock Taper
SCREENER COMPARE ANY 2 STOCKS
TLSI
TRISALUS LIFE SCIENCES, INC.
NASDAQ
$4.83
▼ DOWN 2.03% (-0.10)

KEY STATISTICS

Market Cap$297.41 M
52w High$7.95
52w Low$2.20
Dividend Yield—
Frequency—
P/E-2.87
Volume79.97K
Shares Out.61.57M

COMPANY

LEADERSHIP

Mary T. Szela
CHIEF EXECUTIVE
Mary T. Szela

COMPENSATION 2026

Salary$600,920
Stock Awards$2,570,750
Incentive Plan Pay$0
All Other Comp.$15,797
Total$4,823,349

ABOUT

SECTOR
Healthcare
WENT PUBLIC
February 8, 2021
METHOD OF GOING PUBLIC
SPAC
FULL TIME EMPLOYEES
102

PRICE TARGET

Target High$8.00
Target Low$8.00
Target Median$8.00
Target Consensus$8.00

UPCOMING EARNINGS

DateNov 12, 2026
DayThursday
Rev. Est.$14.02M
NOV
12
THU

PRICE

$4.83 ▼ DOWN 2.03% (−$0.10)
$4.80$4.95$5.109:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM4.83

About TriSalus Life Sciences, Inc.

https://trisaluslifesci.com ↗

TriSalus Life Sciences develops and commercializes immunotherapies and specialized infusion systems for liver and pancreatic tumors, including SD-101, targeting various cancers with liver metastases.

INDUSTRY

Medical - Devices

A PRODUCT TRISALUS LIFE SCIENCES, INC. IS KNOWN FOR

TriNav® XP Infusion System
TriNav® XP Infusion System

The TriNav® XP Infusion System, featuring SmartValve® Technology, enhances tumor drug delivery by overcoming vascular barriers, enabling deeper, targeted therapy while minimizing impact on healthy tissues.

COMPETITORS

COMPETITOR
ANGO COMPARE
BDX COMPARE
BSX COMPARE
DCTH COMPARE
MMSI COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
45
LISTED HERE
8
RANKED BY POSITION SIZE
VTI
0.00% · 1.1M
IWM
0.01% · 1.1M
XRSG.L
0.01% · 42.6K
QQQS
0.70% · 32.8K
R2SC.L
0.00% · 31.9K
RSSL
0.01% · 22.8K
URTY
0.00% · 1.9K
FLQS
0.01% · 1.4K

INSTITUTIONAL OWNERSHIP

SHARES OWNED
29.42%
HOLDERS
97
TOP 12 OF 97 · RANKED BY POSITION SIZE
First Light Asset Management, LLC
5.1M sh · $20.27M
Awm Investment Company, Inc.
2.1M sh · $8.32M
Nantahala Capital Management, LLC
2.1M sh · $8.28M
Blackrock, Inc.
1.5M sh · $10.71M
Vanguard Group Inc
1.5M sh · $10.68M
Wasatch Advisors LP
1.4M sh · $5.75M
Gilder Gagnon Howe & Co LLC
1.0M sh · $4.87M
Cerity Partners LLC
787.3K sh · $3.15M
Geode Capital Management, LLC
777.1K sh · $3.11M
Wealthcare Advisory Partners LLC
643.7K sh · $4.49M
Thompson Siegel & Walmsley LLC
583.6K sh · $2.33M
Alyeska Investment Group, L.P.
557.5K sh · $2.59M

RATINGS SNAPSHOT

Overall rating: D+

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1

INSIDER TRADES

★
OFFICER: CHIEF FINANCIAL OFFICER
Patience David
Sale · 14.7K shares
2026-07-01
★
DIRECTOR, OFFICER: CEO AND PRESIDENT
Szela Mary T
Purchase · 4.0K shares
2026-06-30
★
DIRECTOR, OFFICER: CEO AND PRESIDENT
Szela Mary T
— · —
2025-12-31
★
OFFICER: CHIEF COMMERCIAL OFFICER
Marshak Richard
Purchase · 561 shares
2026-06-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 2
2 GRADES IN THE LAST 12 MONTHS
Lake Street BUY Canaccord Genuity BUY

SECTORS PEERS

PEERPRICE
AVR$8.74COMPARE
PRE$25.76COMPARE
PROF$6.85COMPARE
STIM$2.94COMPARE
MXCT$1.22COMPARE
LNSR$8.30COMPARE
OWLT$4.99COMPARE
NNOX$0.83COMPARE